First-generation EGFR-TKI plus bevacizumab and chemotherapy for advanced EGFR-mutated non-squamous non-small-cell lung cancer: a retrospective study

BACKGROUND: This study aimed to compare the efficacy and safety of different treatment modalities for previously untreated advanced EGFR-mutated non-squamous non-small-cell lung cancer (NSCLC). METHODS: This retrospective study included 196 advanced EGFR-mutated non-squamous NSCLC. 107 received EGFR...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yahua, Du, Bin, Lv, Chengliu, Ji, Xiaohui, Lan, Yanqin, Yao, Na, Zhu, Yingjiao, Lai, Jinhuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413910/
https://www.ncbi.nlm.nih.gov/pubmed/37557185
http://dx.doi.org/10.1080/07853890.2023.2243967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413910/
https://www.ncbi.nlm.nih.gov/pubmed/37557185
http://dx.doi.org/10.1080/07853890.2023.2243967

Ejemplares similares